Emergency medical services (EMS) education is advancing with expanded accreditation, adaptable training formats, and technology-enabled continuing education. CoAEMSP will oversee advanced EMT programs ...

Lower extremity orthopedic disorders, particularly degenerative diseases and related deformities, are a leading cause of pain and disability worldwide, ...

Innovative Directions in Esophagogastric Cancer Care: from Single-center to Real-World EvidenceEsophageal and gastric cancers remain among the most lethal ...

A rolling NDA has been initiated for tinlarebant in STGD1, potentially positioning the first disease-modifying systemic ...

A new study from the Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) at Tufts University suggests that the ...

The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...

First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company ...

C3G and IC-MPGN can be difficult to diagnose because they are so rare and their symptoms are vague and nonspecific. A kidney biopsy is considered the gold standard and usually needed to confirm the ...

Complement 3 glomerulopathy (C3G) is a rare kidney disease that is also considered an autoimmune disorder. There is no single cure for C3G, but several treatments may slow disease progression, protect ...

Cedars-Sinai investigators have identified a genetic variant that increases people's risk of developing perianal Crohn's disease, the most debilitating manifestation of Crohn's disease. Science X ...

The complement system is an innate immune response that leads to increased inflammation. The drug pegcetacoplan—a complement inhibitor—was approved for medical use in the United States in 2021 to ...